Your browser doesn't support javascript.
loading
Reply to: "Do IL-17 inhibitors increase risk of respiratory tract infections?"
Wan, Marilyn T; Shin, Daniel B; Winthrop, Kevin L; Gelfand, Joel M.
Afiliação
  • Wan MT; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia.
  • Shin DB; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia.
  • Winthrop KL; Division of Infectious Diseases and Public Health, Oregon Health & Sciences University, Portland.
  • Gelfand JM; Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia. Electronic address: joel.gelfand@pennmedicine.upenn.edu.
J Am Acad Dermatol ; 83(4): e305-e306, 2020 10.
Article em En | MEDLINE | ID: mdl-32622146
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Infecções Respiratórias / Produtos Biológicos / COVID-19 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Infecções Respiratórias / Produtos Biológicos / COVID-19 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article